Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M667Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-50.7EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)25.4Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.0PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4,800,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IHE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Brown, ArthurDirector, Senior Officer 2016-11-08Buy25,000$0.2849525view
BACH, WENDYSenior Officer 2016-11-08Sell3,549$48.06189.12view
BACH, WENDYSenior Officer 2016-11-08Buy4,619$48.08189view
BACH, WENDYSenior Officer 2016-11-08Sell1,070$48.06189.12view
Miller, James MichaelSenior Officer 2016-11-08Buy5,000$4.33131.4view
Omni-Lite Industries Canada InIssuer 2016-11-08Buy2,300$1.658321.21view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-11-08Buy13,000$0.13106784.62view
Glazier, Patrick L.Director 2016-11-08Buy100,000$0.1499150view
Sutton, Brayden RobertDirector 2016-11-08Buy5,000$0.2849525view
Reilly, Robert BruceSenior Officer 2016-11-08Sell155,000$0.06231483.33view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Two Nano-Cap Pharma Stocks To Watch Right Now Dec 02 2016
    Pfizer Divests Hospira’s Infusion System Business to ICU Medical Nov 29 2016
    Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios Nov 17 2016
    Analyzing Future Estimates for Johnson & Johnson Oct 25 2016
    Pfizer’s Divestment of Hospira Infusion Systems Oct 14 2016
    Medicare Negotiations Would Lead to Huge Cost Savings Oct 03 2016
    Analyzing Donald Trump’s Free-Market Healthcare Sep 30 2016
    How Does Hillary Clinton Plan to Tame Drug Prices? Sep 30 2016
    Generic Drugs Are Crucial in Cost Savings and Accessibility Sep 30 2016
    Getting Into The Drug Business: From NDAs To PDUFA Dates Sep 27 2016
    The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals... Sep 12 2016
    Will a Clinton Presidency Spell Doom for Pharma ETFs? Sep 09 2016
    Why Pfizer’s Vaccines Business Is Declining Sep 01 2016
    Will Xtandi Fuel Pfizer’s Top-Line Growth? Aug 31 2016
    Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns Aug 31 2016
    Analyzing Johnson & Johnson’s Business Segments Aug 30 2016
    Pfizer’s Products with Decreasing Revenues Aug 11 2016
    Pharma ETFs Soaring on Solid Q2 Earnings Aug 03 2016
    Trending on ETFdb.com: Emerging Markets and Dividend Kings Garner Interest Jun 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)